Uliledlimab
Sponsors
TJ Biopharma Co., Ltd.
Conditions
Non Small Cell Lung Cancer
Phase 2
A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer
Active, not recruitingNCT06984588
Start: 2024-03-28End: 2028-09-30Target: 450Updated: 2026-01-30
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
Active, not recruitingNCT07005336
Start: 2025-01-09End: 2029-01-09Target: 150Updated: 2026-01-30